COCONUT CREEK, Fla. – July 22, 2013- Greyson International Inc. (OTC Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that talks with patent law firm Lerner Greenberg Stemer LLP resulted in across the board agreement with Greyson’s plan to help save and stave the potential $90+ billion loss in the pharmaceutical market.

Large pharmaceutical companies are facing a so-called “patent cliff”, whereby brand names drugs, once having delivered steady sales and profits are losing, or have already lost, their patent protection.  Johnson and Johnson (NYSE:JNJ) has had three blockbuster drug patents expire in the last two years, Eli Lilly’s (NYSE:LLY) Cymbalta loses its patent at the end of 2013, and Pfizer (NYSE:PFE) recently attained a short extension on multibillion-dollar Celebrex which expires in Dec. 2015.

Lerner Greenberg Stemer LLP patent law firm for the world’s largest multinational corporations concur with Greyson’s plan to utilize their patented Trilexon® trans-dermal topical delivery system in several ways. “Leveraging our technology, large pharmaceutical companies can potentially reformulate their drugs to be delivered topically instead of orally, extend patent lives, and/or create new patents quickly under the Greyson umbrella” said Harvey Tauman, CEO of Greyson International Inc. “Greyson International, in addition to being debt free, has invested millions over a period of about 20 years culminating to the point whereby preparation is meeting opportunity.”

Currently Greyson International has anchored a large manufacturer, added two prominent physicians as consultants, and recruited top industry beauty consultants for Greyson Skincare® with Trilexon® technology.  Their new spokesperson and brand manager, Tia Castle is preparing to launch Greyson Skincare line on network shopping television toward the fourth quarter of 2013.  Greyson is open to adding new talent to the managerial team as it rapidly expands to meet market demands.  All inquiries may contact Harvey Tauman.

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

 

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

COCONUT CREEK, Fla. – April 10, 2013 — Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that Greyson is forming a subsidiary that will have a business plan which will target the multi-billion dollar pharmaceutical industry.

“Greyson’s management team has been diligently working to launch our new Greyson Biomedical subsidiary and commercialize Trilexon® Delivery System in potentially enormous medical end markets,” said Greyson International Inc. CEO Harvey Tauman. “After demonstrating efficacy in topical applications in OTC products, our goal is to license our patented technology to companies interested in improving efficacy of their existing products   or creating altogether new products.

Greyson International’s patented Trilexon® technology (U.S. Patent 8,268,335) combines a cationic emulsifying agent, oil soluble liquid polymer and naturally occurring lactate buffer system to dramatically improve the topical delivery of active ingredients. Unlike normal delivery agents, the patented formulation effectively delivers active ingredients to the skin at a more desirable pH level to enhance delivery/efficacy.

“We believe there is a lot of potential for Trilexon® Delivery System within the biomedical industry,” added CEO Harvey Tauman. “With more durable and stable delivery of active ingredients, we see potential in prescription products that promote healing, restore damaged cells, and relieve topical pain, as well as topical OTC products like pain relievers, eczema treatment, anti-itch creams, burn relief products, or sunscreens etc. Our team is working diligently to prove these claims and launching the new subsidiary in the near future in order to generate significant long-term value for our shareholders.”

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer
Harvey@greysonintl.com

Greyson International, Inc. Announces the Untimely Death of Its Chairman and CEO

COCONUT CREEK, Fla., July 29, 2014 /PRNewswire/ — Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that Harvey Tauman, the Company’s Chairman and CEO, passed away this morning unexpectedly. Mr. Tauman was 73 years old. He had been hospitalized recently for treatment of respiratory failure.

The Board of Directors issued the following statement: “We are greatly saddened by the passing of Harvey Tauman.  The Company’s directors and employees, as well as the many people he worked with over the years, mourn his loss.  We extend our sympathies to his family.”

C. Mukesh Prasad, the Company’s Director and Vice-President will preside as Chairman and CEO over the interim period.

Chaudhury Mukesh Prasad, Vice President 
Mr. Prasad has served as the Vice President of Operations for Greyson International, Inc. since 2003. He is now serving on the Board of Directors of the Company as well as Corporate Secretary and Executive Vice President. Previously employed for 25 years at Hydron Technologies, Inc., Mr. Prasad held the positions of Controller, Vice President, Corp. Secretary, and member of the board as well as other various operational roles.

Mr. Prasad brings significant hands on managerial experience to Greyson International, Inc.  He assists the Company with product development, production and launch of various skin care and hair care products.  He has extensive experience in business operations, accounting, purchasing, manufacturing, warehousing, fulfillment center, and human resources.  Mr. Prasad studied Physics, Chemistry and Math at collage in India and studied accounting, and management in USA.  He is also an active member of the Society of Cosmetic Chemist.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact
Greyson International Inc.
C. Mukesh Prasad, 954-482-0497
Interim Chief Executive Officer

Greyson International Inc. Garners Investor Interest in a series of Financial Presentations Pre-empting an Investor Conference

COCONUT CREEK, Fl. – Nov. 6, 2013- Greyson International Inc. (OTC Pink Sheets: GYSN), developer of an innovative patented trans-dermal and topical delivery emulsion targeting the multi-billion dollar anti-aging and OTC pharmaceutical industries, unveiled details about the technology as well as business plans and market potential in a three-city series of financial presentations. The multimedia presentation delivered by Greyson Marketing Director, Tia Castle reveals the science behind Trilexon® technology and explains the vast applications in the pharmaceutical and anti-aging market.  A sixty-second preview clip of the presentation is also available which highlights how Trilexon® increases dermal permeation of anti-aging and/or topical pharmaceutical ingredients.

Tony Schor of Investor Awareness, director of the tri-city series remarked, “Now that the Company has a patent for Trilexon and is prepared to launch product, we felt it was the right timing to begin to tell the Greyson story to the financial community thru a series of financial presentations. We look forward to continuing our efforts in generating exposure and awareness on behalf of Greyson across the Country.”

“I felt this presentation explains the technology to both a lay and medical audience. But more importantly, I saw the light bulb go on when the audience of investors realized the enormous potential” said Tia Castle, Greyson International Marketing Director and Spokeswoman. She also added that an investor conference call will take place on Nov. 21, 2013 at 4:15 EST.  A reminder press release will be issued to announce details and the call in phone number.

 

Harvey Tauman, CEO of Greyson Inc. commented, “Our diligence in attaining a patent and test marketing Trilexon® has us on the verge of exploding into the market place as supported by the science you will see explained in this presentation. I am very proud to announce that our team will launch the new product line in the first quarter of 2014.” Greyson International recently hired consultant Joe Bovino, Esq., to head their pharmaceutical licensing division.  Joe has extensive relationships in the pharmaceutical industry having brokered many licensing deals for various companies.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer
Harvey@greysonintl.com

Coconut Creek, Fla. – February 4, 2013 – Greyson International, Inc. (OTCPINK: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it has scheduled an investor conference call for February 20, 2013 at 4:15 pm EDT.  Greyson will provide updates on product development and entry into new product categories, the formation of our Bio-Medical subsidiary, an update on Greyson’s energy assets, as well as an update on all other aspects of Greyson’s business. Conference call specifics will be announced at a later date.

Greyson International CEO Harvey Tauman stated, “Our company has made tremendous progress over the last several months and I’m looking forward to outlining these accomplishments as well as discussing our future plans on this call.”

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Coconut Creek, Fla. – August 24, 2012 – Greyson International, Inc. (GYSN.PK) announced today additional information in regards to its investment in Blake Oil and Gas Limited (“Blake”) a privately owned, Guernsey registered, oil and gas company.

Earlier this year Greyson acquired a private entity that owned 630,690 shares of Blake in exchange for restricted shares of Greyson’s common stock.  Each member of that entity was issued Greyson’s shares based upon their percentage of ownership in that entity.

Greyson International is not an operator of that business.  Its interest is solely as an investor. Although its shares of ownership haven’t changed, its percentage can vary depending upon the outstanding shares of Blake. Its ownership is currently at 3%.

Blake has recently entered into a Joint Venture arrangement to further exploit its Oil and Gas Assets in Georgia. Under terms of the agreement, its partner has committed over $100,000,000 in funding to further develop its oil and gas activities in the Country of Georgia. According to independent studies, these properties have been reported to have significant oil and gas reserves.  For more information please visit their website, www.blakeoilandgas.com.

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook group page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Coconut Creek, Fla. – December 27, 2012– Greyson International, Inc. (Pink Sheets: GYSN), developer of an innovative topical delivery technology, today announced that its common stock listed on OTC Markets has been upgraded to OTC Pink Current Information. The designation is for companies that follow the International Reporting Standard or the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service pursuant to OTC Markets Group Guidelines for Providing Adequate Current Information.

“Our goal is to transition Greyson International to a fully reporting company,” said Harvey Tauman, CEO of Greyson International Inc. “We are pleased that we have reached the highest tier in the OTC Pink Markets by completing and filing three years of audited financials in addition to having all of our quarterly filings released on time. Looking forward, we plan on moving towards an additional up listing to the OTCQB designation.”

Greyson is preparing a complete shareholder update to be released in the near future that will outline recent corporate developments, provide details about its Oil and Gas investment, as well as schedule a time for a shareholder conference call in early 2013.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that targets the multi-billion dollar cosmetics industry. It also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. The Trilexon® system creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Coconut Creek, Fla. – November 7, 2012– Greyson International, Inc. (GYSN.PK) is entering into the $58.3 billion* cosmetic market with the creation of its new tinted Trilexon® foundation, designed to reduce fine lines that form around the eyes and mouth before applying make-ups, blushes and eye shadows. By providing an even tone, the Trilexon® foundation reduces blemishes, wrinkles, and fine lines providing a more uniform facial surface for color products. Trilexon® is the basis for many products utilizing the company’s patented delivery system, both in its existing product offerings and upcoming development pipeline.

“Trilexon® represents a breakthrough in the color cosmetic market that has eluded many of the world’s largest cosmetic companies for years,” said Harvey Tauman, CEO of Greyson International, Inc. “By creating a fine surface that’s insoluble in water, the foundation keeps in place with longer wear times despite sweat or water contact, while continuously releasing ingredients over an extended period of time to give skin a healthy and youthful look.”

Greyson’s Trilexon® technology uses a buffering system based on lactates. The pH is buffered to a range of 4.5-5.0, thus helping to maintain the skins natural pH. Maintaining the natural pH allows the natural intracellular cement of the skin cells to maintain their barrier function thereby promoting healthy skin by sustaining the natural moisture and lipid levels. Many naturally occurring enzymes that contribute to skin health and support healing, like betaglucocerebrosidase, are only active in the pH range of 4.5-5.0. The use of complexes like Dermaxyl and Metrixyl also help to plump the skin and reduce lines and wrinkles, resulting in skin smoothing. And finally, a cationic emulsifier with a prepolymer develops a water resistant film that helps promote moisture retention in the skin and minimize oil and sebum build-up over time.

“We are very excited to leverage our patented delivery system and bring our first color product to market in such a short timeframe,” added Mr. Tauman. “Trilexon® represents a breakthrough in the foundation and skin treatment space and we plan on launching several additional products next year in order to ramp up revenues and generate value for our shareholders.”

* Statistic from the Demeter Group.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that targets the multi-billion dollar cosmetics industry. It also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. The Trilexon® system creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Coconut Creek, Fla. – October 15, 2012– Greyson International, Inc. (GYSN.PK) has received notification from the Depository Trust & Clearing Corporation (“DTCC”) that its shares now have full service eligibility.

Greyson International CEO Harvey Tauman says “Now that our patent has been officially issued, our company can continue the process of shifting from a research and development company into a revenue-generating company. In accordance with our master plan of becoming a full reporting company we are pleased to announce that our securities now have the benefit of DTCC’s depository services. We are requesting that our shareholders notify their brokers of this important development and request that their shares be deposited with DTCC”.

About Greyson International, Inc.

Greyson’s main asset is its recently patented Trilexon® delivery system. It also holds an investment in Blake Oil and Gas Limited (“Blake”) a privately owned, Guernsey registered, Oil and Gas Company.  The Trilexon® delivery system precisely delivers key ingredients to the appropriate areas through “messengers” in order to achieve higher effectiveness and more noticeable results. The Trilexon® system creates a fine surface which is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time; ensuring that the skin receives treatment at a constant steady pace to give the skin a healthy and youthful look. We believe that Trilexon® will have benefits in the medical field and wherever it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

† Trilexon® is a registered trademark of Greyson International, Inc.

COCONUT CREEK, Fla. – January 22, 2013- Greyson International Inc. (Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it engaged beauty and lifestyle futurologist Jeanine Recckio and the Mirror Mirror Imagination Group to bring its patented breakthrough Trilexon® technology and cosmetic products to the next level.

“We are very excited to have engaged Jeanine Recckio to help us effectively introduce both our existing and future product lines into the retail market,” said Harvey Tauman, CEO of Greyson International Inc. “With our patented revolutionary topical Trilexon® delivery technology and several cosmetic products already in place, we are excited to bring our breakthrough products to market and ultimately unlock significant shareholder value over the coming quarters.”

Formerly a top executive at global cosmetic giants like Revlon, Estee Lauder, Coty, L’Oreal, Helena Rubinstein and Ralph Lauren Fragrances, Ms. Recckio’s trend forecasting agency Mirror Mirror Imagination Group© focuses on identifying trends that drive new business, and lending its expertise in developing, packaging, positioning and selling Fortune 500 products into retail channels like Colgate-Palmolive, P&G, Sephora, QVC, Nivea, LaPrairie, Garnier and more to launch innovative products concept to market.

“I am very excited to be working with Greyson’s innovative team,” said Jeanine Recckio. “The company’s technology marks a breakthrough in the cosmetics industry that leading beauty brands need, retailers want, and consumers demand.”

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.

Based on this technology, the company’s breakthrough Trilexon® foundation reduces blemishes, wrinkles and fine lines, providing a more uniform surface for color products, like make-ups, blushes and eye shadows, that remains in place even after contact with water and feels like wearing nothing a

 About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com